Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID-19 pandemic: A guide for surgical oncologists.
J Surg Oncol
; 123(1): 12-23, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-815894
ABSTRACT
The coronavirus disease-2019 (COVID-19) pandemic is deeply impacting the accessibility of cancer patients to surgery. In resource-limited conditions, the standard of care might not be deliverable, but evidence to support alternative management strategies often exists. By revisiting available treatment options, this review provides surgical oncologists with an evidence-based framework for treating patients with gastrointestinal stromal tumor, extremity/truncal soft tissue sarcoma, and retroperitoneal sarcoma to rapidly adapt their decision-making to the constant evolution of the COVID-19 pandemic.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Soft Tissue Neoplasms
/
Practice Guidelines as Topic
/
Gastrointestinal Stromal Tumors
/
SARS-CoV-2
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
J Surg Oncol
Year:
2021
Document Type:
Article
Affiliation country:
Jso.26246
Similar
MEDLINE
...
LILACS
LIS